The final results ensure conclusions drawn by Bagli et al. [1], who done a study that incorporated ten patients diagnosed with CRAO who been given HBOT. As well as receiving twenty periods of HBOT, oral acetazolamide and topical beta-blockers had been administered to the patients on the earliest possible time.OPDIVO® (nivolumab) is often a prescri